The Incidental Economist

This video was adapted from a piece published on the blog on May 29th: A precision public health approach to preventing the next COVID-19 surge: It’s time to talk about surveillance, written by Meredith Matone, DrPH, MHS, and Deanna Marshall, MPH.

@DrTiff_PhD

Following on the heels of Austin’s post from yesterday, I’d like to share my contribution to JHPPL’s Affordable Care Act at 10 edition. Along with my coauthors (Bob Blendon, John Benson, Mary Findling, and Eric Schneider), I evaluated how preferences for different approaches to health reform relate to variations in underlying political attitudes and self-reported […]

According to federal law, the FDA may approve emergency use authorizations on the condition that data on the safety and effectiveness of authorized medications will be collected and analyzed. To protect patients from unsafe drugs and ensure the effectiveness of treatments, the FDA needs to routinely exercise that power.

A weekly round-up of resources and information pertaining to COVID-19.

We review the ACA’s reforms, the subsequent actions that countered them, and the expected and realized effects on coverage, access to care, financial security, health, labor market decisions, and health care spending.

There’s a study coming out of the UK about using a steroid called Dexamethasone to treat COVID19 symptoms. The initial reports look good, but we’ll hold judgement until we see the full study. (The pre-print of this article is now available: https://bit.ly/2VfZrpf). Toilet plumes are also in the news. Apparently, flushing a toilet may throw […]

Cecille Joan Avila is a Policy Analyst at Boston University School of Public Health. She tweets at @cecilleavila. “Vulnerable” is often used to avoid the discomfort associated with naming structural racism as the true root cause of many public health problems. Sometimes referring to those who are clinically vulnerable to disease because of their age […]

A weekly round-up of resources and information pertaining to COVID-19.

Sometimes I write pieces and can’t place them. I usually save them for later. In this case, I feel strongly enough about it that I’m posting it here. It won’t get the eyeballs it might at a major media site, but it’s more important to me that I publish it now. Public health has a […]

A significant study on the safety of hydroxychloroquine as a treatment for COVID-19 has been retracted. So, what does this mean? What does it say about using the drug to treat COVID? What does it say about the way we do science?   @DrTiff_PhD